Sfoglia per AUTORE
PEROTTI P
Collezione AOU San Luigi di Orbassano

  

Items : 20

Serendipitous Adrenal Hyperplasia in Patients Admitted to the Emergency Department for Suspected SARS-CoV-2 Infection is Linked to Increased Mortality. in Archives of medical research / Arch Med Res. 2024 Jun;55(4):103010. doi: 10.1016/j.arcmed.2024.103010. Epub 2024 May 27.
2024
AOU San Luigi di Orbassano

Reimondo G; Solitro F; Puglisi S; Balbi M; Tiranti GM; Perini AME; Cultrera A; Brero D; Botto C; Perotti P; Caramello V; Boccuzzi A; Pia A; Veltri A; Terzolo M;

Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Jul;205:114088. doi: 10.1016/j.ejca.2024.114088. Epub 2024 Apr 26.
2024
AOU San Luigi di Orbassano

Scatolini M; Grisanti S; Tomaiuolo P; Grosso E; Basile V; Cosentini D; Puglisi S; Laganà M; Perotti P; Saba L; Rossini E; Palermo F; Sigala S; Volante M; Berruti A; Terzolo M;

The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients. in European journal of endocrinology / Eur J Endocrinol. 2023 Jan 10;188(1):lvad002. doi: 10.1093/ejendo/lvad002.
2023
AOU San Luigi di Orbassano

Calabrese A; Puglisi S; Borin C; Basile V; Perotti P; Pia A; Berchialla P; Volante M; Fiori C; Porpiglia F; Veltri A; Reimondo G; Terzolo M;

Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro Studies. in Cancers / Cancers (Basel). 2021 Oct 20;13(21):5255. doi: 10.3390/cancers13215255.
2021
AOU San Luigi di Orbassano

Lo Iacono M; Puglisi S; Perotti P; Saba L; Petiti J; Giachino C; Reimondo G; Terzolo M;

Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer. in Cancers / Cancers (Basel). 2020 Sep 14;12(9):2615. doi: 10.3390/cancers12092615.
2020
AOU San Luigi di Orbassano

Basile V; Puglisi S; Calabrese A; Pia A; Perotti P; Berruti A; Reimondo G; Terzolo M;

New perspectives for mitotane treatment of adrenocortical carcinoma. in Best practice & research. Clinical endocrinology & metabolism / Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101415. doi: 10.1016/j.beem.2020.101415. Epub 2
2020
AOU San Luigi di Orbassano

Puglisi S; Calabrese A; Basile V; Pia A; Reimondo G; Perotti P; Terzolo M;

Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma. in Cancers / Cancers (Basel). 2020 Mar 20;12(3):740. doi: 10.3390/cancers12030740.
2020
AOU San Luigi di Orbassano

Puglisi S; Calabrese A; Basile V; Ceccato F; Scaroni C; Altieri B; Della Casa S; Loli P; Pivonello R; De Martino MC; Canu L; Russo M; Badalamenti G; Torlontano M; Stigliano A; Ferraù F; Arnaldi G; Saba L; Quirino A; Perotti P; Berchialla P; Terzolo M;

Determination of salivary cortisol to assess time-related changes of the adrenal response to stress in critically ill patients. in European journal of internal medicine / Eur J Intern Med. 2019 Oct;68:66-70. doi: 10.1016/j.ejim.2019.08.001. Epub 2019 Aug 6.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Reimondo G; Perotti P; Palmas E; Aprà F; Panero F; Laface B; Pizzuto A; Puglisi S; Boccuzzi A; Terzolo M;

Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment. in Journal of clinical medicine / J Clin Med. 2019 Nov 2;8(11):1850. doi: 10.3390/jcm8111850.
2019
AOU San Luigi di Orbassano

Puglisi S; Calabrese A; Basile V; Ceccato F; Scaroni C; Simeoli C; Torlontano M; Cannavò S; Arnaldi G; Stigliano A; Malandrino P; Saba L; Altieri B; Della Casa S; Perotti P; Berchialla P; De Filpo G; Canu L; Loli P; Reimondo G; Terzolo M;

Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. in European journal of endocrinology / Eur J Endocrinol. 2019 Jun 1;180(6):387-396. doi: 10.1530/EJE-18-0923.
2019
AOU San Luigi di Orbassano

Calabrese A; Basile V; Puglisi S; Perotti P; Pia A; Saba L; Berchialla P; Porpiglia F; Veltri A; Volante M; Reimondo G; Berruti A; Terzolo M;

Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. in European journal of endocrinology / Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570.
2019
AOU San Luigi di Orbassano

Cosentini D; Badalamenti G; Grisanti S; Basile V; Rapa I; Cerri S; Spallanzani A; Perotti P; Musso E; Laganà M; Ferrari VD; Luppi G; Dalla Volta A; Incorvaia L; Sigala S; Russo A; Volante M; Terzolo M; Berruti A;

PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA. in Endocrine connections / Endocr Connect. 2018 Sep 1;7(11):1227-35. doi: 10.1530/EC-18-0400.
2018
AOU San Luigi di Orbassano

Puglisi S; Perotti P; Barbot M; Cosio P; Scaroni C; Stigliano A; Lardo P; Morelli V; Polledri E; Chiodini I; Reimondo G; Pia A; Terzolo M;

Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2018 Nov;18(11):1125-1133. doi: 10.1080/14737140.2018.1510325. Epub 2018
2018
AOU San Luigi di Orbassano

Puglisi S; Perotti P; Cosentini D; Roca E; Basile V; Berruti A; Terzolo M;

Adrenocortical Carcinoma with Hypercortisolism. in Endocrinology and metabolism clinics of North America / Endocrinol Metab Clin North Am. 2018 Jun;47(2):395-407. doi: 10.1016/j.ecl.2018.02.003. Epub 2018 Ap
2018
AOU San Luigi di Orbassano

Puglisi S; Perotti P; Pia A; Reimondo G; Terzolo M;

Immunotherapy failure in adrenocortical cancer: where next? in Endocrine connections / Endocr Connect. 2018 Dec;7(12):E5-E8. doi: 10.1530/EC-18-0398.
2018
AOU San Luigi di Orbassano

Cosentini D; Grisanti S; Dalla Volta A; Laganà M; Fiorentini C; Perotti P; Sigala S; Berruti A;

CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells. in PloS one / PLoS One. 2018 May 7;13(5):e0196931. doi: 10.1371/journal.pone.0196931. eCollection 2018.
2018
AOU San Luigi di Orbassano

Germano A; Saba L; De Francia S; Rapa I; Perotti P; Berruti A; Volante M; Terzolo M;

Analysis of BCLI, N363S and ER22/23EK Polymorphisms of the Glucocorticoid Receptor Gene in Adrenal Incidentalomas. in PloS one / PLoS One. 2016 Sep 20;11(9):e0162437. doi: 10.1371/journal.pone.0162437. eCollection 2016.
2016
AOU San Luigi di Orbassano

Reimondo G; Chiodini I; Puglisi S; Pia A; Morelli V; Kastelan D; Cannavo S; Berchialla P; Giachino D; Perotti P; Cuccurullo A; Paccotti P; Beck-Peccoz P; De Marchi M; Terzolo M;

18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2015 Dec;173(6):749-56. doi: 10.1530/EJE-15-0707. Epub 2015 Sep 7.
2015
AOU San Luigi di Orbassano

Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M;

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. in European journal of endocrinology / Eur J Endocrinol. 2013 Jul 29;169(3):263-70. doi: 10.1530/EJE-13-0242. Print 2013 Sep.
2013
AOU San Luigi di Orbassano

Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A;

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2012 Mar;166(3):451-8. doi: 10.1530/EJE-11-0918. Epub 2011 Dec 21.
2012
AOU San Luigi di Orbassano

Berruti A; Sperone P; Ferrero A; Germano A; Ardito A; Priola AM; De Francia S; Volante M; Daffara F; Generali D; Leboulleux S; Perotti P; Baudin E; Papotti M; Terzolo M;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte